Spisek R - Search Results

1

Trial watch: Dendritic cell-based anticancer therapy.

Bloy N, Pol J, Aranda F, Eggermont A, Cremer I, Fridman WH, Fučíková J, Galon J, Tartour E, Spisek R, Dhodapkar MV, Zitvogel L, Kroemer G, Galluzzi L. Bloy N, et al. Among authors: spisek r. Oncoimmunology. 2014 Dec 21;3(11):e963424. doi: 10.4161/21624011.2014.963424. eCollection 2014 Nov. Oncoimmunology. 2014. PMID: 25941593 Free PMC article. Review.

2

Immunoprevention of cancer.

Spisek R, Dhodapkar MV. Spisek R, et al. Hematol Oncol Clin North Am. 2006 Jun;20(3):735-50. doi: 10.1016/j.hoc.2006.02.009. Hematol Oncol Clin North Am. 2006. PMID: 16762732 Review.

3

Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications.

Spisek R, Charalambous A, Mazumder A, Vesole DH, Jagannath S, Dhodapkar MV. Spisek R, et al. Blood. 2007 Jun 1;109(11):4839-45. doi: 10.1182/blood-2006-10-054221. Epub 2007 Feb 13. Blood. 2007. PMID: 17299090 Free PMC article.

4

Dendritic cells are specialized accessory cells along with TGF- for the differentiation of Foxp3+ CD4+ regulatory T cells from peripheral Foxp3 precursors.

Yamazaki S, Bonito AJ, Spisek R, Dhodapkar M, Inaba K, Steinman RM. Yamazaki S, et al. Among authors: spisek r. Blood. 2007 Dec 15;110(13):4293-302. doi: 10.1182/blood-2007-05-088831. Epub 2007 Aug 15. Blood. 2007. PMID: 17699744 Free PMC article.

5

Towards a better way to die with chemotherapy: role of heat shock protein exposure on dying tumor cells.

Spisek R, Dhodapkar MV. Spisek R, et al. Cell Cycle. 2007 Aug 15;6(16):1962-5. doi: 10.4161/cc.6.16.4601. Epub 2007 Jun 18. Cell Cycle. 2007. PMID: 17721082 Review.

6

FOCUS on FOCIS: combined chemo-immunotherapy for the treatment of hormone-refractory metastatic prostate cancer.

Rozková D, Tiserová H, Fucíková J, Last'ovicka J, Podrazil M, Ulcová H, Budínský V, Prausová J, Linke Z, Minárik I, Sedivá A, Spísek R, Bartůnková J. Rozková D, et al. Among authors: spisek r. Clin Immunol. 2009 Apr;131(1):1-10. doi: 10.1016/j.clim.2009.01.001. Epub 2009 Feb 8. Clin Immunol. 2009. PMID: 19201656 Review.

7

Human tumor cells killed by anthracyclines induce a tumor-specific immune response.

Fucikova J, Kralikova P, Fialova A, Brtnicky T, Rob L, Bartunkova J, Spísek R. Fucikova J, et al. Among authors: spisek r. Cancer Res. 2011 Jul 15;71(14):4821-33. doi: 10.1158/0008-5472.CAN-11-0950. Epub 2011 May 20. Cancer Res. 2011. PMID: 21602432

8

Poly I: C-activated dendritic cells that were generated in CellGro for use in cancer immunotherapy trials.

Fučíková J, Rožková D, Ulčová H, Budinský V, Sochorová K, Pokorná K, Bartůňková J, Špíšek R. Fučíková J, et al. Among authors: spisek r. J Transl Med. 2011 Dec 30;9:223. doi: 10.1186/1479-5876-9-223. J Transl Med. 2011. PMID: 22208910 Free PMC article.

9

Effects of 5-azacytidine and trichostatin A on dendritic cell maturation.

Stepanek I, Indrova M, Bieblova J, Fucikova J, Spisek R, Bubenik J, Reinis M. Stepanek I, et al. Among authors: spisek r. J Biol Regul Homeost Agents. 2011 Oct-Dec;25(4):517-29. J Biol Regul Homeost Agents. 2011. PMID: 22217985

10

Dynamics of T-cell infiltration during the course of ovarian cancer: the gradual shift from a Th17 effector cell response to a predominant infiltration by regulatory T-cells.

Fialová A, Partlová S, Sojka L, Hromádková H, Brtnický T, Fučíková J, Kocián P, Rob L, Bartůňková J, Spíšek R. Fialová A, et al. Among authors: spisek r. Int J Cancer. 2013 Mar 1;132(5):1070-9. doi: 10.1002/ijc.27759. Epub 2012 Aug 24. Int J Cancer. 2013. PMID: 22865582

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters